(CNN) — A federal advisory committee meets today to weigh the risks and benefits of using MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder.
A panel of top scientists has warned the FDA against approving MDMA for post-traumatic stress disorder (PTSD), despite widespread calls from campaigners to offer the party drug to sick patients.
Nikhil Tandon and colleagues explore the impact of a quality improvement strategy for patients with type 2 diabetes 6.5 years after its implementation for the CARRS randomised trial.
MultiChoice Malawi urges parental control mwnation.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mwnation.com Daily Mail and Mail on Sunday newspapers.
Genetic Variants Linked To 42% Of Individual Differences In Antidepressant Response science20.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science20.com Daily Mail and Mail on Sunday newspapers.